tacrine, (Cognex - discontinued in the U.S.)
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: tacrine
BRAND NAME: Cognex (Discontinued in the USA)
DRUG CLASS AND MECHANISM: Tacrine is an oral medication used to treat patients with Alzheimer's disease. Tacrine is in a class of drugs called cholinesterase inhibitors that also includes rivastigmine (Exelon), donepezil (Aricept), and galantamine (Razadyne - formerly Reminyl). Cholinesterase inhibitors inhibit (block) the action of acetylcholinesterase, the enzyme responsible for the destruction of acetylcholine. Acetylcholine is one of several neurotransmitters in the brain, chemicals that nerve cells use to communicate with one another. Reduced levels of acetylcholine in the brain are believed to be responsible for some of the symptoms of Alzheimer's disease. By blocking the enzyme that destroys acetylcholine, rivastigmine increases the concentration of acetylcholine in the brain, and this increase is believed to be responsible for the improvement in thinking seen with tacrine. Tacrine was approved by the FDA in 1993.
GENERIC AVAILABLE: No
PREPARATIONS: Capsules: 10, 20, 30, and 40 mg.
STORAGE: Capsules should be stored at room temperature, 15-30 C (59-86 F).
PRESCRIBED FOR: Tacrine is used for the treatment of mild to moderate dementia of the Alzheimer's type.
DOSING: The recommended dose is 10 to 20 mg four times daily. The maximum dose is 160 mg daily. Tacrine is usually taken on an empty stomach (one hour before, or two hours after meals) unless it causes stomach upset.
DRUG INTERACTIONS: Drugs with anticholinergic properties and which cross into the brain, such as atropine, benztropine (Cogentin), and trihexyphenidyl (Artane) produce opposite effects of tacrine and should be avoided during therapy with tacrine. Unlike donezepril (Aricept), tacrine does not reduce the elimination of other drugs, increasing their levels in blood and the likelihood of their side effects.
PREGNANCY: Animal reproduction studies have not been done with tacrine. It is not known if tacrine causes fetal harm when taken by a pregnant woman.
NURSING MOTHERS: Tacrine may pass into breast milk and be harmful to the nursing infant; it should not be used while nursing.
SIDE EFFECTS: The most common side effect of tacrine is an increase in a liver test called alanine aminotransferase (ALT) as a result of liver damage. When a patient starts taking tacrine, blood is drawn on a weekly basis to measure ALT. If there is an increase in blood ALT, the dosage of tacrine can be reduced. Other side effects of tacrine include nausea, indigestion, vomiting, diarrhea, abdominal pain, and skin rash.
Reference: FDA Prescribing Information
Last Editorial Review: 7/19/2012
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index